Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/29923
DC FieldValueLanguage
dc.contributor.authorAngelovska Petrushevska, Natalijaen_US
dc.contributor.authorMitreski, Nenaden_US
dc.contributor.authorAngelovska, Biljanaen_US
dc.contributor.authorKlisarovska, Violetaen_US
dc.contributor.authorAngelovski, Tomeen_US
dc.date.accessioned2024-04-08T06:25:35Z-
dc.date.available2024-04-08T06:25:35Z-
dc.date.issued2014-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/29923-
dc.language.isoenen_US
dc.publisherOxford University Press on behalf of the European Society for Medical Oncologyen_US
dc.relation.ispartofAnnals of Oncology 2014en_US
dc.titleTrastuzumab in Her-2 positive advancd gastric carcinoma – long term survivorsen_US
dc.typeProceeding articleen_US
dc.relation.conferenceESMO 14th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 25-28 June 2014.en_US
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
2014 ESMO.pdf69.16 kBAdobe PDFView/Open
Show simple item record

Page view(s)

68
checked on May 4, 2025

Download(s)

10
checked on May 4, 2025

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.